XOLAIR
Live / Registered — Registered — international registration renewed (as of 27 Jun 2025)
What this means for you
Registered since 04 Jun 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Jun 2029: the §71 ten-year affidavit of use).
Record
- Serial number
- 79250397
- Registration number
- 5766518
- Mark type
- Word mark
- Filed
- 30 Oct 2018
- Published for opposition
- 19 Mar 2019
- Registered
- 04 Jun 2019
- Next maintenance filing
- §71 ten-year affidavit of use, due by 04 Jun 2029 (grace period to 04 Dec 2029)
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of severe allergic reactions following exposure to an allergen
Owner
- Novartis AG, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 26 Aug 2026 — NOTICE OF SUIT
- 27 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 27 Jun 2025 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 26 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Mar 2025 — TEAS SECTION 71 & 15 RECEIVED
- 16 Aug 2019 — NOTIFICATION PROCESSED BY IB
- 30 Jul 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 30 Jul 2019 — FINAL DISPOSITION PROCESSED
- 04 Jul 2019 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 04 Jun 2019 — REGISTERED-PRINCIPAL REGISTER
- 19 Mar 2019 — PUBLISHED FOR OPPOSITION
- 27 Feb 2019 — NOTICE OF PUBLICATION
- 05 Feb 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Feb 2019 — ASSIGNED TO EXAMINER
- 02 Feb 2019 — APPLICATION FILING RECEIPT MAILED